ViaNautis is on a mission to exploit the unique capabilities of the revolutionary polyNaut® technology. Here are details of ViaNautis‘ latest funding round :
🚀 Launch
2018
🏭 Industry
Biotechnology
🧠Management
Francesca Crawford (CEO)
💸 Funding & Investors
| INVESTMENT (Novembre 2023) | $25 million (Series A) |
| INVESTORS (Novembre 2023) | led by 4BIO Capital, BGF, and UCB Ventures with participation from the Cystic Fibrosis Foundation, Eli Lilly and Company and existing investors including Origin Capital, Meltwind and O2H. |
🎯 Funding purpose
Accelerate the development of products using the polyNaut® platform, expand the scientific and management teams and establish laboratory facilities.
🌐 Country HQ
UK (Cambridge)